nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—FABP2—Estradiol—prostate cancer	0.153	0.206	CbGbCtD
Sulfinpyrazone—CYP3A4—prostate cancer	0.101	1	CbGaD
Sulfinpyrazone—ABCC1—Abiraterone—prostate cancer	0.0415	0.0559	CbGbCtD
Sulfinpyrazone—ABCC6—Etoposide—prostate cancer	0.0381	0.0514	CbGbCtD
Sulfinpyrazone—ABCC3—Conjugated Estrogens—prostate cancer	0.0319	0.0431	CbGbCtD
Sulfinpyrazone—ABCC6—Doxorubicin—prostate cancer	0.026	0.0351	CbGbCtD
Sulfinpyrazone—ABCC4—Conjugated Estrogens—prostate cancer	0.0244	0.0329	CbGbCtD
Sulfinpyrazone—ABCC2—Ethinyl Estradiol—prostate cancer	0.0198	0.0267	CbGbCtD
Sulfinpyrazone—ABCC1—Conjugated Estrogens—prostate cancer	0.0196	0.0265	CbGbCtD
Sulfinpyrazone—ABCC3—Etoposide—prostate cancer	0.0183	0.0247	CbGbCtD
Sulfinpyrazone—CYP2C8—Nilutamide—prostate cancer	0.0178	0.0241	CbGbCtD
Sulfinpyrazone—ABCC1—Mitoxantrone—prostate cancer	0.0178	0.0241	CbGbCtD
Sulfinpyrazone—CYP2C8—Abiraterone—prostate cancer	0.0148	0.0199	CbGbCtD
Sulfinpyrazone—ABCC2—Conjugated Estrogens—prostate cancer	0.0145	0.0196	CbGbCtD
Sulfinpyrazone—ABCC1—Epirubicin—prostate cancer	0.0144	0.0195	CbGbCtD
Sulfinpyrazone—CYP2B6—Estrone—prostate cancer	0.0141	0.019	CbGbCtD
Sulfinpyrazone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0138	0.0186	CbGbCtD
Sulfinpyrazone—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0126	0.017	CbGbCtD
Sulfinpyrazone—ABCC3—Doxorubicin—prostate cancer	0.0125	0.0168	CbGbCtD
Sulfinpyrazone—CYP2C9—Bicalutamide—prostate cancer	0.0124	0.0168	CbGbCtD
Sulfinpyrazone—CYP2C9—Nilutamide—prostate cancer	0.0124	0.0168	CbGbCtD
Sulfinpyrazone—ABCC1—Etoposide—prostate cancer	0.0112	0.0152	CbGbCtD
Sulfinpyrazone—ABCB1—Estramustine—prostate cancer	0.0112	0.0151	CbGbCtD
Sulfinpyrazone—CYP2C8—Cabazitaxel—prostate cancer	0.0109	0.0148	CbGbCtD
Sulfinpyrazone—ABCC1—Docetaxel—prostate cancer	0.0103	0.0139	CbGbCtD
Sulfinpyrazone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00953	0.0129	CbGbCtD
Sulfinpyrazone—ABCC2—Etoposide—prostate cancer	0.00832	0.0112	CbGbCtD
Sulfinpyrazone—ABCC1—Doxorubicin—prostate cancer	0.00767	0.0103	CbGbCtD
Sulfinpyrazone—ABCC2—Docetaxel—prostate cancer	0.00761	0.0103	CbGbCtD
Sulfinpyrazone—CYP2C9—Estrone—prostate cancer	0.00745	0.0101	CbGbCtD
Sulfinpyrazone—ABCB1—Cabazitaxel—prostate cancer	0.0074	0.00998	CbGbCtD
Sulfinpyrazone—CYP3A4—Bicalutamide—prostate cancer	0.00724	0.00976	CbGbCtD
Sulfinpyrazone—ABCB1—Estrone—prostate cancer	0.00723	0.00976	CbGbCtD
Sulfinpyrazone—CYP3A4—Estramustine—prostate cancer	0.00673	0.00907	CbGbCtD
Sulfinpyrazone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00645	0.0087	CbGbCtD
Sulfinpyrazone—CYP2C8—Estradiol—prostate cancer	0.00614	0.00828	CbGbCtD
Sulfinpyrazone—CYP3A4—Abiraterone—prostate cancer	0.006	0.00809	CbGbCtD
Sulfinpyrazone—CYP3A4—Flutamide—prostate cancer	0.006	0.00809	CbGbCtD
Sulfinpyrazone—ABCC2—Doxorubicin—prostate cancer	0.00568	0.00766	CbGbCtD
Sulfinpyrazone—CYP2C9—Capecitabine—prostate cancer	0.00565	0.00762	CbGbCtD
Sulfinpyrazone—ABCB1—Conjugated Estrogens—prostate cancer	0.00473	0.00638	CbGbCtD
Sulfinpyrazone—CYP3A4—Cabazitaxel—prostate cancer	0.00443	0.00598	CbGbCtD
Sulfinpyrazone—CYP3A4—Estrone—prostate cancer	0.00433	0.00585	CbGbCtD
Sulfinpyrazone—FABP2—epithelium—prostate cancer	0.00432	0.119	CbGeAlD
Sulfinpyrazone—ABCB1—Mitoxantrone—prostate cancer	0.0043	0.0058	CbGbCtD
Sulfinpyrazone—CYP2C9—Estradiol—prostate cancer	0.00428	0.00578	CbGbCtD
Sulfinpyrazone—ABCB1—Estradiol—prostate cancer	0.00415	0.00561	CbGbCtD
Sulfinpyrazone—CYP2C8—Etoposide—prostate cancer	0.00401	0.00541	CbGbCtD
Sulfinpyrazone—SLC22A12—renal system—prostate cancer	0.004	0.11	CbGeAlD
Sulfinpyrazone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00386	0.00521	CbGbCtD
Sulfinpyrazone—CYP2B6—Doxorubicin—prostate cancer	0.00361	0.00487	CbGbCtD
Sulfinpyrazone—ABCB1—Prednisone—prostate cancer	0.00357	0.00482	CbGbCtD
Sulfinpyrazone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00284	0.00383	CbGbCtD
Sulfinpyrazone—ABCB1—Etoposide—prostate cancer	0.00271	0.00366	CbGbCtD
Sulfinpyrazone—CYP3A4—Mitoxantrone—prostate cancer	0.00258	0.00348	CbGbCtD
Sulfinpyrazone—CYP3A4—Estradiol—prostate cancer	0.00249	0.00336	CbGbCtD
Sulfinpyrazone—ABCB1—Docetaxel—prostate cancer	0.00248	0.00335	CbGbCtD
Sulfinpyrazone—ABCC6—Podofilox—Etoposide—prostate cancer	0.00221	1	CbGdCrCtD
Sulfinpyrazone—CYP3A4—Prednisone—prostate cancer	0.00214	0.00289	CbGbCtD
Sulfinpyrazone—CYP2C9—urine—prostate cancer	0.00208	0.0571	CbGeAlD
Sulfinpyrazone—FABP2—lymph node—prostate cancer	0.00188	0.0516	CbGeAlD
Sulfinpyrazone—ABCB1—Doxorubicin—prostate cancer	0.00185	0.0025	CbGbCtD
Sulfinpyrazone—ABCC6—renal system—prostate cancer	0.00167	0.0459	CbGeAlD
Sulfinpyrazone—ABCC5—prostate gland—prostate cancer	0.00167	0.0458	CbGeAlD
Sulfinpyrazone—CYP3A4—Etoposide—prostate cancer	0.00163	0.00219	CbGbCtD
Sulfinpyrazone—CYP3A4—urine—prostate cancer	0.00158	0.0435	CbGeAlD
Sulfinpyrazone—CYP3A4—Docetaxel—prostate cancer	0.00149	0.00201	CbGbCtD
Sulfinpyrazone—ABCC3—prostate gland—prostate cancer	0.0014	0.0385	CbGeAlD
Sulfinpyrazone—ABCC4—prostate gland—prostate cancer	0.00116	0.0318	CbGeAlD
Sulfinpyrazone—ABCC2—prostate gland—prostate cancer	0.00112	0.0307	CbGeAlD
Sulfinpyrazone—CYP3A4—Doxorubicin—prostate cancer	0.00111	0.0015	CbGbCtD
Sulfinpyrazone—ABCC1—prostate gland—prostate cancer	0.000985	0.0271	CbGeAlD
Sulfinpyrazone—ABCC3—renal system—prostate cancer	0.000954	0.0262	CbGeAlD
Sulfinpyrazone—ABCC5—bone marrow—prostate cancer	0.000859	0.0236	CbGeAlD
Sulfinpyrazone—ABCC1—seminal vesicle—prostate cancer	0.000833	0.0229	CbGeAlD
Sulfinpyrazone—ABCC4—renal system—prostate cancer	0.000787	0.0216	CbGeAlD
Sulfinpyrazone—ABCC2—renal system—prostate cancer	0.000762	0.021	CbGeAlD
Sulfinpyrazone—ABCC5—testis—prostate cancer	0.000734	0.0202	CbGeAlD
Sulfinpyrazone—ABCC1—urethra—prostate cancer	0.00066	0.0181	CbGeAlD
Sulfinpyrazone—ABCC3—testis—prostate cancer	0.000617	0.0169	CbGeAlD
Sulfinpyrazone—ABCC4—bone marrow—prostate cancer	0.000595	0.0164	CbGeAlD
Sulfinpyrazone—Clotrimazole—CYP17A1—prostate cancer	0.000584	0.231	CrCbGaD
Sulfinpyrazone—CYP2C8—renal system—prostate cancer	0.000572	0.0157	CbGeAlD
Sulfinpyrazone—ABCC5—lymph node—prostate cancer	0.000532	0.0146	CbGeAlD
Sulfinpyrazone—CYP2B6—renal system—prostate cancer	0.000513	0.0141	CbGeAlD
Sulfinpyrazone—ABCC4—testis—prostate cancer	0.000509	0.014	CbGeAlD
Sulfinpyrazone—ABCC2—testis—prostate cancer	0.000493	0.0135	CbGeAlD
Sulfinpyrazone—ABCC3—lymph node—prostate cancer	0.000447	0.0123	CbGeAlD
Sulfinpyrazone—ABCC1—testis—prostate cancer	0.000434	0.0119	CbGeAlD
Sulfinpyrazone—ABCB1—prostate gland—prostate cancer	0.000402	0.0111	CbGeAlD
Sulfinpyrazone—CYP3A4—renal system—prostate cancer	0.000387	0.0106	CbGeAlD
Sulfinpyrazone—CYP2C8—testis—prostate cancer	0.000369	0.0102	CbGeAlD
Sulfinpyrazone—ABCC4—lymph node—prostate cancer	0.000369	0.0101	CbGeAlD
Sulfinpyrazone—ABCC2—lymph node—prostate cancer	0.000357	0.00982	CbGeAlD
Sulfinpyrazone—ABCB1—seminal vesicle—prostate cancer	0.00034	0.00935	CbGeAlD
Sulfinpyrazone—CYP2B6—testis—prostate cancer	0.000331	0.00911	CbGeAlD
Sulfinpyrazone—ABCC1—lymph node—prostate cancer	0.000315	0.00865	CbGeAlD
Sulfinpyrazone—Clotrimazole—CYP2A6—prostate cancer	0.000312	0.123	CrCbGaD
Sulfinpyrazone—Clotrimazole—CYP19A1—prostate cancer	0.000297	0.117	CrCbGaD
Sulfinpyrazone—ABCB1—epithelium—prostate cancer	0.000295	0.00812	CbGeAlD
Sulfinpyrazone—ABCB1—renal system—prostate cancer	0.000274	0.00753	CbGeAlD
Sulfinpyrazone—ABCB1—urethra—prostate cancer	0.000269	0.0074	CbGeAlD
Sulfinpyrazone—Cinnarizine—CYP2A6—prostate cancer	0.000264	0.104	CrCbGaD
Sulfinpyrazone—Clotrimazole—CYP2E1—prostate cancer	0.000222	0.0875	CrCbGaD
Sulfinpyrazone—Clotrimazole—CYP2C19—prostate cancer	0.00022	0.0867	CrCbGaD
Sulfinpyrazone—ABCB1—bone marrow—prostate cancer	0.000207	0.0057	CbGeAlD
Sulfinpyrazone—Cinnarizine—CYP1A1—prostate cancer	0.000185	0.073	CrCbGaD
Sulfinpyrazone—ABCB1—testis—prostate cancer	0.000177	0.00487	CbGeAlD
Sulfinpyrazone—Phenylbutazone—CYP3A4—prostate cancer	0.000156	0.0615	CrCbGaD
Sulfinpyrazone—Phenylbutazone—PTGS2—prostate cancer	0.000153	0.0602	CrCbGaD
Sulfinpyrazone—Clotrimazole—CYP3A4—prostate cancer	0.00014	0.0551	CrCbGaD
Sulfinpyrazone—ABCB1—lymph node—prostate cancer	0.000128	0.00353	CbGeAlD
Sulfinpyrazone—CYP2B6—Metabolism—RXRA—prostate cancer	3.9e-06	3.34e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CB—prostate cancer	3.86e-06	3.31e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.86e-06	3.3e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.85e-06	3.29e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP2E1—prostate cancer	3.83e-06	3.28e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTGS2—prostate cancer	3.83e-06	3.28e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—HPGDS—prostate cancer	3.83e-06	3.28e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—AKR1C3—prostate cancer	3.82e-06	3.27e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PIK3CA—prostate cancer	3.81e-06	3.27e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—JAK2—prostate cancer	3.81e-06	3.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PRKACB—prostate cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NQO1—prostate cancer	3.79e-06	3.25e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP17A1—prostate cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—COMT—prostate cancer	3.75e-06	3.21e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—INS—prostate cancer	3.74e-06	3.2e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—TH—prostate cancer	3.74e-06	3.2e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTP1—prostate cancer	3.73e-06	3.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.72e-06	3.19e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MDM2—prostate cancer	3.72e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—UCP3—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA3—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TCN2—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PDHA1—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTT1—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ACHE—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.7e-06	3.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.68e-06	3.15e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ITPR1—prostate cancer	3.68e-06	3.15e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.67e-06	3.14e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CREBBP—prostate cancer	3.66e-06	3.14e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—ERBB2—prostate cancer	3.66e-06	3.14e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.66e-06	3.13e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.63e-06	3.11e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CB—prostate cancer	3.62e-06	3.1e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NCOA2—prostate cancer	3.58e-06	3.07e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTGS2—prostate cancer	3.58e-06	3.07e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.57e-06	3.06e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PRKACB—prostate cancer	3.55e-06	3.04e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.54e-06	3.04e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.54e-06	3.04e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GGT1—prostate cancer	3.52e-06	3.02e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.51e-06	3.01e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CD—prostate cancer	3.47e-06	2.98e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—TYMS—prostate cancer	3.47e-06	2.97e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NCOA1—prostate cancer	3.47e-06	2.97e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.47e-06	2.97e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTM1—prostate cancer	3.43e-06	2.94e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—SLC5A5—prostate cancer	3.42e-06	2.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.42e-06	2.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA4—prostate cancer	3.4e-06	2.91e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.4e-06	2.91e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CDKN1B—prostate cancer	3.39e-06	2.91e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IL6—prostate cancer	3.38e-06	2.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—LPL—prostate cancer	3.37e-06	2.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NCOA2—prostate cancer	3.35e-06	2.87e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP2E1—prostate cancer	3.34e-06	2.86e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTEN—prostate cancer	3.34e-06	2.86e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA2—prostate cancer	3.31e-06	2.84e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NQO1—prostate cancer	3.3e-06	2.83e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—RXRA—prostate cancer	3.3e-06	2.83e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—NOS3—prostate cancer	3.28e-06	2.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCG5—prostate cancer	3.27e-06	2.8e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.27e-06	2.8e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—TH—prostate cancer	3.26e-06	2.79e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP1A1—prostate cancer	3.25e-06	2.79e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ERCC2—prostate cancer	3.23e-06	2.76e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP3A4—prostate cancer	3.22e-06	2.76e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.21e-06	2.75e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CTNNB1—prostate cancer	3.21e-06	2.75e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PIK3CA—prostate cancer	3.19e-06	2.74e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.19e-06	2.74e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTA1—prostate cancer	3.19e-06	2.74e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—EP300—prostate cancer	3.18e-06	2.73e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—COMT—prostate cancer	3.18e-06	2.72e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP1B1—prostate cancer	3.17e-06	2.71e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTP1—prostate cancer	3.16e-06	2.71e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTO1—prostate cancer	3.16e-06	2.71e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.16e-06	2.71e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NAT2—prostate cancer	3.16e-06	2.71e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CDKN1A—prostate cancer	3.13e-06	2.68e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTEN—prostate cancer	3.12e-06	2.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.12e-06	2.67e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—AKT1—prostate cancer	3.12e-06	2.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ITPR1—prostate cancer	3.11e-06	2.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NQO1—prostate cancer	3.09e-06	2.64e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GGT1—prostate cancer	3.07e-06	2.63e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.06e-06	2.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—TH—prostate cancer	3.04e-06	2.6e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—MTHFR—prostate cancer	3.03e-06	2.6e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CB—prostate cancer	3.03e-06	2.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PLCB2—prostate cancer	3.03e-06	2.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—LRP2—prostate cancer	3.03e-06	2.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.03e-06	2.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.02e-06	2.59e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NCOA1—prostate cancer	3.02e-06	2.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.01e-06	2.58e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTGS2—prostate cancer	3e-06	2.57e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.99e-06	2.56e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EP300—prostate cancer	2.98e-06	2.55e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP19A1—prostate cancer	2.98e-06	2.55e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PPARA—prostate cancer	2.98e-06	2.55e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—P4HB—prostate cancer	2.97e-06	2.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.96e-06	2.53e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—TYMS—prostate cancer	2.94e-06	2.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTM1—prostate cancer	2.91e-06	2.49e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SRC—prostate cancer	2.9e-06	2.48e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.89e-06	2.47e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—RXRA—prostate cancer	2.87e-06	2.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GGT1—prostate cancer	2.86e-06	2.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—LPL—prostate cancer	2.85e-06	2.44e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NCOA1—prostate cancer	2.82e-06	2.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.81e-06	2.41e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CAV1—prostate cancer	2.8e-06	2.4e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—STAT3—prostate cancer	2.79e-06	2.39e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.78e-06	2.38e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MED12—prostate cancer	2.77e-06	2.37e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—COMT—prostate cancer	2.77e-06	2.37e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTP1—prostate cancer	2.75e-06	2.36e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.75e-06	2.36e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GNG5—prostate cancer	2.75e-06	2.35e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ERCC2—prostate cancer	2.73e-06	2.34e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ITPR1—prostate cancer	2.71e-06	2.32e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—RXRA—prostate cancer	2.68e-06	2.3e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.65e-06	2.27e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTEN—prostate cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.61e-06	2.24e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—AKT1—prostate cancer	2.61e-06	2.24e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MYC—prostate cancer	2.6e-06	2.22e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TGFB1—prostate cancer	2.59e-06	2.22e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—COMT—prostate cancer	2.59e-06	2.21e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—MTHFR—prostate cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—TYMS—prostate cancer	2.56e-06	2.19e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.55e-06	2.18e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EGFR—prostate cancer	2.54e-06	2.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ITPR1—prostate cancer	2.53e-06	2.17e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTM1—prostate cancer	2.53e-06	2.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.52e-06	2.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PPARA—prostate cancer	2.52e-06	2.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.51e-06	2.15e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—EP300—prostate cancer	2.49e-06	2.14e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.49e-06	2.13e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—LPL—prostate cancer	2.48e-06	2.13e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.45e-06	2.1e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ACHE—prostate cancer	2.45e-06	2.1e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.42e-06	2.07e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—INS—prostate cancer	2.41e-06	2.07e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP1A1—prostate cancer	2.4e-06	2.06e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—KRAS—prostate cancer	2.4e-06	2.05e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—TYMS—prostate cancer	2.39e-06	2.05e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ERCC2—prostate cancer	2.38e-06	2.04e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CAV1—prostate cancer	2.37e-06	2.03e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTM1—prostate cancer	2.36e-06	2.03e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CREBBP—prostate cancer	2.36e-06	2.02e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CA—prostate cancer	2.36e-06	2.02e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.35e-06	2.02e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.34e-06	2.01e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—LPL—prostate cancer	2.32e-06	1.99e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.32e-06	1.99e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.26e-06	1.94e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.24e-06	1.92e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.24e-06	1.92e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—MTHFR—prostate cancer	2.24e-06	1.92e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ERCC2—prostate cancer	2.22e-06	1.9e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.21e-06	1.89e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CA—prostate cancer	2.2e-06	1.89e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PPARA—prostate cancer	2.19e-06	1.88e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.16e-06	1.85e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—NOS3—prostate cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—MTHFR—prostate cancer	2.09e-06	1.79e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CAV1—prostate cancer	2.06e-06	1.77e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.06e-06	1.76e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PPARA—prostate cancer	2.05e-06	1.76e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—INS—prostate cancer	2.04e-06	1.75e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NQO1—prostate cancer	2.03e-06	1.74e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TH—prostate cancer	2.01e-06	1.72e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CREBBP—prostate cancer	2e-06	1.71e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.95e-06	1.67e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6—prostate cancer	1.95e-06	1.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.95e-06	1.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTGS2—prostate cancer	1.93e-06	1.66e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CAV1—prostate cancer	1.93e-06	1.65e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—AKT1—prostate cancer	1.92e-06	1.65e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.9e-06	1.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GGT1—prostate cancer	1.89e-06	1.62e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.88e-06	1.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.86e-06	1.59e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CA—prostate cancer	1.85e-06	1.58e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.84e-06	1.58e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.83e-06	1.57e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—AKT1—prostate cancer	1.8e-06	1.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NOS3—prostate cancer	1.79e-06	1.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—INS—prostate cancer	1.78e-06	1.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—RXRA—prostate cancer	1.77e-06	1.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.76e-06	1.5e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CREBBP—prostate cancer	1.74e-06	1.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—COMT—prostate cancer	1.71e-06	1.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.7e-06	1.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTEN—prostate cancer	1.69e-06	1.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.67e-06	1.43e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—INS—prostate cancer	1.66e-06	1.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.65e-06	1.42e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.65e-06	1.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTGS2—prostate cancer	1.64e-06	1.4e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.63e-06	1.39e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—EP300—prostate cancer	1.61e-06	1.38e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TYMS—prostate cancer	1.58e-06	1.35e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NOS3—prostate cancer	1.56e-06	1.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.56e-06	1.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.54e-06	1.32e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—LPL—prostate cancer	1.53e-06	1.31e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—AKT1—prostate cancer	1.51e-06	1.29e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.48e-06	1.27e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.47e-06	1.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NOS3—prostate cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.44e-06	1.23e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTEN—prostate cancer	1.43e-06	1.22e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTGS2—prostate cancer	1.43e-06	1.22e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.38e-06	1.18e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—EP300—prostate cancer	1.36e-06	1.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PPARA—prostate cancer	1.35e-06	1.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CAV1—prostate cancer	1.27e-06	1.09e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTEN—prostate cancer	1.24e-06	1.07e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—EP300—prostate cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTEN—prostate cancer	1.16e-06	9.96e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.16e-06	9.92e-06	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—EP300—prostate cancer	1.11e-06	9.5e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—INS—prostate cancer	1.1e-06	9.39e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.07e-06	9.2e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.02e-06	8.72e-06	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.01e-06	8.63e-06	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—AKT1—prostate cancer	9.72e-07	8.33e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NOS3—prostate cancer	9.61e-07	8.24e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.87e-07	7.6e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTGS2—prostate cancer	8.79e-07	7.53e-06	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CA—prostate cancer	8.78e-07	7.52e-06	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—AKT1—prostate cancer	8.23e-07	7.05e-06	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CA—prostate cancer	8.2e-07	7.03e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTEN—prostate cancer	7.67e-07	6.57e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—EP300—prostate cancer	7.31e-07	6.26e-06	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—AKT1—prostate cancer	7.17e-07	6.14e-06	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—AKT1—prostate cancer	6.7e-07	5.74e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.41e-07	4.63e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AKT1—prostate cancer	4.42e-07	3.79e-06	CbGpPWpGaD
